New medication may 'cure' high blood pressure years after you stop

A new research line around baxdrostat, a drug designed to reduce aldosterone production, suggests high blood pressure could improve for up to two years after patients stop treatment. The medication, taken as daily tablets over a six- to 12-month regimen, lowered blood pressure during use, and additional findings reported sustained benefits afterward. The research, led by Prof Morris Brown of Queen Mary University of London, said just under a quarter of patients came off all treatment with completely normal blood pressure. Hypertension affects about one in three adults in the UK (roughly 16 million), and the UK’s NICE is assessing baxdrostat for potential NHS availability next year. Earlier trials involved 796 patients across 214 clinics and showed larger reductions versus placebo.